Geftinat 250mg Tablet contains Gefitinib, a potent tyrosine kinase inhibitor that specifically targets the epidermal growth factor receptor (EGFR). This medication is widely used in the treatment of non-small cell lung cancer (NSCLC). By interfering with EGFR’s signaling pathways, Gefitinib disrupts cancer cell growth, making it a vital component in targeted cancer therapy.
Key Features:
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.